199 related articles for article (PubMed ID: 10467142)
1. Crystal structure of Pseudomonas fluorescens 4-hydroxyphenylpyruvate dioxygenase: an enzyme involved in the tyrosine degradation pathway.
Serre L; Sailland A; Sy D; Boudec P; Rolland A; Pebay-Peyroula E; Cohen-Addad C
Structure; 1999 Aug; 7(8):977-88. PubMed ID: 10467142
[TBL] [Abstract][Full Text] [Related]
2. 4-Hydroxyphenylpyruvate dioxygenase.
Moran GR
Arch Biochem Biophys; 2005 Jan; 433(1):117-28. PubMed ID: 15581571
[TBL] [Abstract][Full Text] [Related]
3. Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC.
Brownlee JM; Johnson-Winters K; Harrison DH; Moran GR
Biochemistry; 2004 Jun; 43(21):6370-7. PubMed ID: 15157070
[TBL] [Abstract][Full Text] [Related]
4. Characterization and safety evaluation of HPPD W336, a modified 4-hydroxyphenylpyruvate dioxygenase protein, and the impact of its expression on plant metabolism in herbicide-tolerant MST-FGØ72-2 soybean.
Dreesen R; Capt A; Oberdoerfer R; Coats I; Pallett KE
Regul Toxicol Pharmacol; 2018 Aug; 97():170-185. PubMed ID: 29894735
[TBL] [Abstract][Full Text] [Related]
5. The crystal structures of Zea mays and Arabidopsis 4-hydroxyphenylpyruvate dioxygenase.
Fritze IM; Linden L; Freigang J; Auerbach G; Huber R; Steinbacher S
Plant Physiol; 2004 Apr; 134(4):1388-400. PubMed ID: 15084729
[TBL] [Abstract][Full Text] [Related]
6. Engineering p-hydroxyphenylpyruvate dioxygenase to a p-hydroxymandelate synthase and evidence for the proposed benzene oxide intermediate in homogentisate formation.
Gunsior M; Ravel J; Challis GL; Townsend CA
Biochemistry; 2004 Jan; 43(3):663-74. PubMed ID: 14730970
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for herbicidal inhibitor selectivity revealed by comparison of crystal structures of plant and mammalian 4-hydroxyphenylpyruvate dioxygenases.
Yang C; Pflugrath JW; Camper DL; Foster ML; Pernich DJ; Walsh TA
Biochemistry; 2004 Aug; 43(32):10414-23. PubMed ID: 15301540
[TBL] [Abstract][Full Text] [Related]
8. Role of the N-terminus in human 4-hydroxyphenylpyruvate dioxygenase activity.
Feng AN; Huang CW; Lin CH; Chang YL; Ni MY; Lee HJ
J Biochem; 2020 Mar; 167(3):315-322. PubMed ID: 31722428
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic and computational studies of NTBC bound to the non-heme iron enzyme (4-hydroxyphenyl)pyruvate dioxygenase: active site contributions to drug inhibition.
Neidig ML; Decker A; Kavana M; Moran GR; Solomon EI
Biochem Biophys Res Commun; 2005 Dec; 338(1):206-14. PubMed ID: 16197918
[TBL] [Abstract][Full Text] [Related]
10. Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione.
Kavana M; Moran GR
Biochemistry; 2003 Sep; 42(34):10238-45. PubMed ID: 12939152
[TBL] [Abstract][Full Text] [Related]
11. 4-hydroxyphenylpyruvate dioxygenase catalysis: identification of catalytic residues and production of a hydroxylated intermediate shared with a structurally unrelated enzyme.
Raspail C; Graindorge M; Moreau Y; Crouzy S; Lefèbvre B; Robin AY; Dumas R; Matringe M
J Biol Chem; 2011 Jul; 286(29):26061-70. PubMed ID: 21613226
[TBL] [Abstract][Full Text] [Related]
12. An archetypical extradiol-cleaving catecholic dioxygenase: the crystal structure of catechol 2,3-dioxygenase (metapyrocatechase) from Ppseudomonas putida mt-2.
Kita A; Kita S; Fujisawa I; Inaka K; Ishida T; Horiike K; Nozaki M; Miki K
Structure; 1999 Jan; 7(1):25-34. PubMed ID: 10368270
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the mechanism of hydroxylation by 4-hydroxyphenylpyruvate dioxygenase and hydroxymandelate synthase from intermediate partitioning in active site variants.
Shah DD; Conrad JA; Heinz B; Brownlee JM; Moran GR
Biochemistry; 2011 Sep; 50(35):7694-704. PubMed ID: 21815644
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Ndikuryayo F; Kang WM; Wu FX; Yang WC; Yang GF
Eur J Med Chem; 2019 Mar; 166():22-31. PubMed ID: 30684868
[TBL] [Abstract][Full Text] [Related]
15. 4-Hydroxyphenylpyruvate dioxygenase and hydroxymandelate synthase: exemplars of the α-keto acid dependent oxygenases.
Moran GR
Arch Biochem Biophys; 2014 Feb; 544():58-68. PubMed ID: 24211436
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
Ellis MK; Whitfield AC; Gowans LA; Auton TR; Provan WM; Lock EA; Smith LL
Toxicol Appl Pharmacol; 1995 Jul; 133(1):12-9. PubMed ID: 7597701
[TBL] [Abstract][Full Text] [Related]
17. Mode of action of 4-hydroxyphenylpyruvate dioxygenase inhibition by triketone-type inhibitors.
Wu CS; Huang JL; Sun YS; Yang DY
J Med Chem; 2002 May; 45(11):2222-8. PubMed ID: 12014960
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization and purification of a p-hydroxyphenylpyruvate dioxygenase from cultured carrot cells and characterization of the corresponding cDNA.
Garcia I; Rodgers M; Lenne C; Rolland A; Sailland A; Matringe M
Biochem J; 1997 Aug; 325 ( Pt 3)(Pt 3):761-9. PubMed ID: 9271098
[TBL] [Abstract][Full Text] [Related]
19. Role of substrate positioning in the catalytic reaction of 4-hydroxyphenylpyruvate dioxygenase-A QM/MM Study.
Wójcik A; Broclawik E; Siegbahn PE; Lundberg M; Moran G; Borowski T
J Am Chem Soc; 2014 Oct; 136(41):14472-85. PubMed ID: 25157877
[TBL] [Abstract][Full Text] [Related]
20. p-Hydroxyphenylpyruvate dioxygenase inhibitor-resistant plants.
Matringe M; Sailland A; Pelissier B; Rolland A; Zink O
Pest Manag Sci; 2005 Mar; 61(3):269-76. PubMed ID: 15633191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
